New pooled data from three Galderma studies of the Restylane portfolio will be presented, demonstrating that treatments with Restylane RefyneTM and Restylane DefyneTM not only enhance ...

L’Oréal just announced it acquired a 10% stake in Galderma, characterized as a “pure play dermatology leader” in injectibles with Botox-competitor Dysport, and Restylane filler brands.